These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9113126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW, Zhang SP, Qin ZH, Weiss B.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [Abstract] [Full Text] [Related]

  • 3. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP, Zhou LW, Weiss B.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Dec; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 6. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Turgeon SM, Fink JS.
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [Abstract] [Full Text] [Related]

  • 7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 11. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 12. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA, Gerfen CR.
    Neuroscience; 1995 Jun 28; 66(4):903-13. PubMed ID: 7651617
    [Abstract] [Full Text] [Related]

  • 13. Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.
    Zhou LW, Zhang SP, Connell TA, Weiss B.
    Neurochem Int; 1993 Mar 28; 22(3):301-11. PubMed ID: 8443571
    [Abstract] [Full Text] [Related]

  • 14. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun 28; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 15. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 28; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 16. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats.
    Cai G, Zhen X, Uryu K, Friedman E.
    J Neurosci; 2000 Mar 01; 20(5):1849-57. PubMed ID: 10684886
    [Abstract] [Full Text] [Related]

  • 17. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates.
    Zhang M, Creese I.
    Neurosci Lett; 1993 Oct 29; 161(2):223-6. PubMed ID: 7903803
    [Abstract] [Full Text] [Related]

  • 18. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE, Thomas LI.
    Pharmacol Biochem Behav; 2010 Jan 29; 94(3):346-51. PubMed ID: 19800912
    [Abstract] [Full Text] [Related]

  • 19. Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors.
    Weiss B, Davidkova G, Zhou LW, Zhang SP, Morabito M.
    Neurochem Int; 1997 Oct 29; 31(4):571-80. PubMed ID: 9308007
    [Abstract] [Full Text] [Related]

  • 20. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML, Currie RW, Robertson HA.
    Neuroscience; 1995 May 29; 66(2):347-59. PubMed ID: 7477877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.